Prognostic factors for skeletal complications from metastatic bone disease in breast cancer

Janet E. Brown, Richard J. Cook, Allan Lipton, Luis Costa, Robert E. Coleman

Research output: Contribution to journalArticlepeer-review

62 Scopus citations


Skeletal morbidity is common in patients with bone metastases from breast cancer (BC) and can undermine patients' functional independence and quality of life. Previously defined prognostic factors may not reflect current treatment standards and the use of antiresorptive therapies. Wereport a comprehensive multivariate analysis of potential prognostic factors for skeletal-related events (SREs) using data from a phase III, randomized study of zoledronic acid in patients with bone metastases from BC. The trial evaluated the number and timing of SREs (pathologic fracture, palliative radiotherapy to bone, surgery to bone to treat or prevent a fracture, and spinal cord compression) and assessed variables for prognostic significance in univariate and multivariate Cox-regression analyses. Continuous variables were categorized with predefined cutpoints. All associations with P<0.05 were considered significant. A total of 444 zoledronic acid-Treated patients with assessments of biochemical markers of bone metabolism and complete baseline variable data were included. Significant baseline prognostic factors for occurrence of a first SRE by multivariate analyses included age, pain score, prior history of an SRE, predominant lesion type, elevated bone-specific alkaline phosphatase, and lactate dehydrogenase. Prior fracture was found to be prognostic in a reduced multivariate analysis of time to first fracture, but not for time to first palliative radiotherapy. In conclusion, this model identified several prognostic factors that may be useful in routine clinical care. Validation of these factors in a separate dataset and generation of a prognostic risk score are recommended next steps.

Original languageEnglish (US)
Pages (from-to)767-779
Number of pages13
JournalBreast Cancer Research and Treatment
Issue number3
StatePublished - Oct 2010

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research


Dive into the research topics of 'Prognostic factors for skeletal complications from metastatic bone disease in breast cancer'. Together they form a unique fingerprint.

Cite this